The comparatively high enrichment of macrophages and less both CD8+ T cells and B cells indicated an immunosuppressed TME and poor survival in the high-SPI group of HNSCC, who might be benefited from ICBs targeting PD-L1 or macrophage in the future. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.